XML 47 R32.htm IDEA: XBRL DOCUMENT v3.21.1
General & Administrative Expenses (Tables)
12 Months Ended
Dec. 31, 2020
General & Administrative Expenses [Abstract]  
General and Administrative Expenses
General and Administrative Expenses:

(Dollars in thousands)
 
2020
  
2019
  
2018
Total Compensation to Employees and Directors
 
$
14,163
  
$
10,331
  
$
11,289
Office and Administrative Expenses
  
2,413
   
2,633
   
2,449
Audit, Legal and Consultancy
  
1,313
   
1,826
   
1,314
Total General and Administrative Expenses
 
$
17,890
  
$
14,789
  
$
15,052
Stock Compensation Series
Stock Compensation Series
 
    
Number of
shares/ options
  
Vesting
Period
  
Fair value
at grant date
(1) Granted October 2005, stock options
  
965
 
10 years
 
$
144.00
(2) Granted March 2012, restricted shares
  
14,515
 
3 years
  
13.80
(3) Granted June 2013, restricted shares
  
155,000
 
4 years
  
4.15
(4) Granted June 2013, stock options
  
155,000
 
5 years
  
1.31
(5) Granted June 2013, stock options
  
155,000
 
5 years
  
0.97
(6) Granted February 2014, restricted shares
  
29,333
 
3 years
  
6.92
(7) Granted February 2014, restricted shares
  
29,333
 
3 years
  
6.33
(8) Granted February 2014, restricted shares
  
29,333
 
3 years
  
5.63
(9) Granted February 2014, restricted shares
  
88,000
 
3 years
  
7.61
(10) Granted June 2014, restricted shares
  
95,666
 
3 years
  
6.41
(11) Granted June 2014, restricted shares
  
95,666
 
3 years
  
5.74
(12) Granted June 2014, restricted shares
  
95,666
 
3 years
  
5.13
(13) Granted June 2014, restricted shares
  
287,000
 
3 years
  
7.15
(14) Granted January 2015, restricted shares
  
850,000
 
3 years
  
8.81
(15) Granted January 2016, restricted shares
  
824,000
 
2 years
  
6.65
(16) Granted January 2017, restricted shares
  
900,000
 
2 years
  
4.61
(17) Granted January 2018, restricted shares
  
355,000
 
1 year
  
3.92
(18) Granted January 2018, restricted shares
  
212,000
 
3 years
  
2.30
(19) Granted January 2019, restricted shares
  
360,000
 
3 years
  
4.25
(20) Granted January 2019, restricted shares
  
200,000
 
3 years
  
3.04
(21) Granted March 2019, restricted shares
  
210,000
 
1 year
  
4.60
(22) Granted January 2020, restricted shares
  
460,000
 
3 years
  
8.22
(23) Granted January 2020, restricted shares
  
150,000
 
1 year
  
8.22
(24) Granted January 2020, restricted shares
  
200,000
 
1 year
 

3.5637
Reconciliation of Outstanding Restricted Common Stock and Share Options
The following reconciles the number of outstanding restricted common stock and share options:
 
  
Restricted
common stock
  
Share options
  
Weighted average exercise price **
         
Outstanding at December 31, 2017
  
1,086,331
   
310,000
  $
9.64
Granted
  
567,000
        
Exercised*
  
1,085,331
        
Forfeited
  
22,500
   
310,000
   
9.64
Outstanding at December 31, 2018
  
545,500
   
-
  
$
-
            
Outstanding at December 31, 2018
  
545,500
   
-
  $
-
Granted
  
770,000
        
Exercised*
  
755,500
        
Forfeited
  
-
        
Outstanding at December 31, 2019
  
560,000
   
-
  
$
-
            
Outstanding at December 31, 2019
  
560,000
   
-
  $
-
Granted
  
810,000
        
Exercised*
  
550,002
        
Forfeited
  
-
        
Outstanding at December 31, 2020
  
819,998
   
-
  
$
-


*Does not include shares in lieu of dividends
**To be adjusted for dividends declared and paid subsequent to the respective grant dates.
Stock Compensation Expense
Stock Compensation Expense
 
(Dollars in thousands)
 
2020
  
2019
  
2018
Expense recognized from stock compensation
 
$
4,792
  
$
2,532
  
$
2,458
Remuneration of Executives and Directors
Remuneration of Directors and Executives as a group:
 
(Dollars in thousands)
 
2020
  
2019
  
2018
Cash compensation
 
$
3,897
  
$
3,518
  
$
3,989
Pension cost
  
33
   
36
   
202
Share compensation*
  
4,364
   
2,003
   
2,250
Total remuneration
 
$
8,293
  
$
5,556
  
$
6,441


* Share compensation reflects the expense recognized.
Shares held by Executives and Directors
Shares held by Directors and Executives:
 
  
2020
  
2019
  
2018
Directors and Executives as a group*
  
2,303,011
   
3,615,221
   
3,155,503


*Includes 619,998 (2019: 440,000, 2018: 465,000) shares of restricted stock subject to vesting conditions.